ARMYO

Egalet Corp (NASDAQ: EGLT) and Ophthotech Corp (NASDAQ: OPHT) have catalysts coming up before the end of the year that can bring glory or spell doom for these companies. Upcoming Catalysts The former is awaiting FDA decision on ARYMO ER, its lead drug candidate, which is an abuse-deterrent...